{"id":287,"date":"2026-10-13T02:21:00","date_gmt":"2026-10-13T02:21:00","guid":{"rendered":"https:\/\/ncglobalhealth.com\/?p=287"},"modified":"2026-10-13T02:21:01","modified_gmt":"2026-10-13T02:21:01","slug":"lung-cancer-targeted-therapy-resistance-immunotherapy","status":"publish","type":"post","link":"https:\/\/ncglobalhealth.com\/ru\/lung-cancer-targeted-therapy-resistance-immunotherapy\/","title":{"rendered":"Lung Cancer Targeted Therapy Resistance: Reawakening the Immune System"},"content":{"rendered":"<p class=\"wp-block-paragraph\">For many patients diagnosed with advanced non-small cell lung cancer (NSCLC) harboring specific genetic mutations (such as EGFR or ALK), targeted therapy initially feels like a miracle. These precision oral medications can shrink tumors rapidly, control the disease, and offer a high quality of life.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, oncology science acknowledges a harsh reality: lung cancer targeted therapy resistance is almost clinically inevitable. After an average of 10 to 14 months of successful disease control, tumors often find a way to evade the drug, leading to disease progression. Discovering that a targeted drug has stopped working can be devastating, but it is not the end of the medical road. Advanced biological immunotherapy and combination strategies now offer powerful &#8220;Plan B&#8221; pathways.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">1. Why Does Advanced Lung Cancer Develop Resistance?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Cancer cells are highly adaptable, operating under the rules of microscopic Darwinian evolution. When a targeted therapy effectively blocks the primary pathway a tumor uses to grow, the surviving cancer cells begin to mutate to stay alive. This acquired resistance typically happens in two ways:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Secondary Mutations:<\/strong> The cancer cell&#8217;s DNA changes just enough so that the targeted drug can no longer bind to its receptor (e.g., the T790M or C797S mutations in EGFR-driven lung cancer).<\/li>\n\n\n\n<li><strong>Bypass Track Activation:<\/strong> The tumor effectively builds a &#8220;detour.&#8221; It activates a completely different genetic pathway to fuel its growth, rendering the original targeted drug useless. In some cases, the tumor may even undergo a histological transformation, changing from non-small cell to small cell lung cancer.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">2. The Crucial Next Step: Re-biopsy and Genomic Profiling<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When targeted therapy resistance occurs, the absolute most critical next step is a re-biopsy (either a tissue biopsy or a liquid biopsy via blood draw).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You must think of the resistant tumor as a brand-new disease. The genetic profile it had when first diagnosed has changed. Comprehensive Next-Generation Sequencing (NGS) is required to map out the tumor&#8217;s new genetic landscape. Without this updated genetic blueprint, oncologists cannot accurately recommend the next line of defense.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">3. Biological Immunotherapy: Reawakening the Immune System<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">If the re-biopsy shows that there are no subsequent generations of targeted pills available for the new mutation, oncologists frequently turn to Biological Immunotherapy (such as PD-1 or PD-L1 immune checkpoint inhibitors).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Unlike targeted therapies or chemotherapy, which attack the cancer directly, immunotherapy works by empowering the patient&#8217;s own body. Lung cancer cells are notorious for wearing a &#8220;protein disguise&#8221; (PD-L1) that essentially hypnotizes the body&#8217;s immune T-cells, preventing them from recognizing the tumor as a threat. Biological immunotherapy strips away this disguise, reawakening the immune system so that T-cells can hunt down and destroy the resistant cancer cells.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">4. Combination Strategies: Maximizing Treatment Efficacy<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Clinical studies have shown that for patients with specific driver mutations (like EGFR), single-agent immunotherapy might not be strong enough to overcome the highly suppressed tumor microenvironment. Therefore, elite oncology centers often utilize combination strategies:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immunotherapy + Chemotherapy:<\/strong> Chemotherapy helps break open the cancer cells, releasing tumor antigens that make it easier for the immune system (boosted by immunotherapy) to recognize and attack the cancer.<\/li>\n\n\n\n<li><strong>Immunotherapy + Anti-angiogenesis Drugs:<\/strong> Tumors build chaotic, abnormal blood vessels to feed themselves. Anti-angiogenesis drugs normalize these blood vessels, which improves oxygen flow into the tumor and allows immune T-cells to penetrate the cancer mass much more effectively.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">5. Accessing Advanced Biological Immunotherapy with Novacare<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When facing targeted therapy resistance, timing and access to multidisciplinary expertise are everything. International patients often find that their local healthcare systems lack the rapid access to complex combination trials or top-tier immune-oncology experts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Novacare is an international patient service desk dedicated to organizing precision oncology access in China. We assist global patients and medical agencies by:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Structuring complex medical records, previous treatment timelines, and new genomic sequencing reports.<\/li>\n\n\n\n<li>Coordinating remote medical reviews with leading biological immunotherapy specialists.<\/li>\n\n\n\n<li>Organizing seamless medical travel pathways for advanced salvage therapies.<\/li>\n\n\n\n<li><strong>For Medical Agencies &amp; Partners:<\/strong> Enhance your cross-border medical portfolio by offering your clients structured oncology referral pathways when their standard targeted therapies fail.<\/li>\n\n\n\n<li><strong>For Patients and Families:<\/strong> Resistance does not mean defeat. Contact the Novacare patient desk to submit your latest medical records and explore advanced immunological treatment options.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions (FAQ)<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q: Can I switch directly to immunotherapy as soon as my targeted therapy stops working?<\/strong><br>A: Not necessarily. The clinical protocol requires an updated genetic test (re-biopsy) first. Sometimes, the new mutation can be treated with a next-generation targeted pill. If no targeted option is available, a combination of immunotherapy and other systemic treatments is usually considered by the oncology board.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q: Why is immunotherapy often combined with chemotherapy for resistant lung cancer?<\/strong><br>A: Cancers with driver mutations (like EGFR or ALK) often have a &#8220;cold&#8221; tumor microenvironment, meaning there are very few active immune cells around the tumor. Chemotherapy acts as a catalyst, destroying some cancer cells and creating inflammation that draws immune cells into the area, making the immunotherapy significantly more effective.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Q: Is a liquid biopsy (blood test) enough after targeted therapy resistance?<\/strong><br>A: A liquid biopsy is a fantastic, non-invasive tool to check for circulating tumor DNA (ctDNA) and identify new mutations. However, if the liquid biopsy is negative or inconclusive, a traditional tissue biopsy is still highly recommended to rule out histological transformation (such as the cancer changing cell types).<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Disclaimer: This article is for educational and informational purposes only and does not constitute a treatment guarantee or medical advice. Treatment for advanced lung cancer must be customized by licensed oncology specialists based on individual diagnostic data.<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>For many patients diagnosed with advanced non-small cell lung cancer (NSCLC) harboring specific genetic mutations (such as EGFR or ALK), targeted therapy initially feels like a miracle. These precision oral medications can shrink tumors rapidly, control the disease, and offer a high quality of life. However, oncology science acknowledges a harsh reality: lung cancer targeted [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[79,76,78,26,66,77],"class_list":["post-287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-precision-oncology","tag-biological-immunotherapy","tag-lung-cancer","tag-nsclc","tag-oncology-referral","tag-precision-oncology","tag-targeted-therapy-resistance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lung Cancer Targeted Therapy Resistance &amp; Immunotherapy<\/title>\n<meta name=\"description\" content=\"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ncglobalhealth.com\/ru\/lung-cancer-targeted-therapy-resistance-immunotherapy\/\" \/>\n<meta property=\"og:locale\" content=\"ru_RU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lung Cancer Targeted Therapy Resistance &amp; Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ncglobalhealth.com\/ru\/lung-cancer-targeted-therapy-resistance-immunotherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"ncglobalhealth.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61591372681524\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-13T02:21:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-13T02:21:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1254\" \/>\n\t<meta property=\"og:image:height\" content=\"1254\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin@qq.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin@qq.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 \u043c\u0438\u043d\u0443\u0442\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/\"},\"author\":{\"name\":\"admin@qq.com\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#\\\/schema\\\/person\\\/1340f27ee6eb785edcfbca839ac6f110\"},\"headline\":\"Lung Cancer Targeted Therapy Resistance: Reawakening the Immune System\",\"datePublished\":\"2026-10-13T02:21:00+00:00\",\"dateModified\":\"2026-10-13T02:21:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/\"},\"wordCount\":924,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp\",\"keywords\":[\"Biological Immunotherapy\",\"Lung Cancer\",\"NSCLC\",\"Oncology Referral\",\"Precision Oncology\",\"Targeted Therapy Resistance\"],\"articleSection\":[\"Precision Oncology\"],\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/\",\"url\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/\",\"name\":\"Lung Cancer Targeted Therapy Resistance & Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp\",\"datePublished\":\"2026-10-13T02:21:00+00:00\",\"dateModified\":\"2026-10-13T02:21:01+00:00\",\"description\":\"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#breadcrumb\"},\"inLanguage\":\"ru-RU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp\",\"contentUrl\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp\",\"width\":1254,\"height\":1254,\"caption\":\"Microscopic visualization of biological immunotherapy targeting lung cancer cells after resistance\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/lung-cancer-targeted-therapy-resistance-immunotherapy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/ncglobalhealth.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lung Cancer Targeted Therapy Resistance: Reawakening the Immune System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#website\",\"url\":\"https:\\\/\\\/ncglobalhealth.com\\\/\",\"name\":\"ncglobalhealth.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ncglobalhealth.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ru-RU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#organization\",\"name\":\"ncglobalhealth.com\",\"url\":\"https:\\\/\\\/ncglobalhealth.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/logo-nuojian.webp\",\"contentUrl\":\"https:\\\/\\\/ncglobalhealth.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/logo-nuojian.webp\",\"width\":1600,\"height\":1213,\"caption\":\"ncglobalhealth.com\"},\"image\":{\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61591372681524\",\"https:\\\/\\\/www.instagram.com\\\/novacareintl\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ncglobalhealth.com\\\/#\\\/schema\\\/person\\\/1340f27ee6eb785edcfbca839ac6f110\",\"name\":\"admin@qq.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ru-RU\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g\",\"caption\":\"admin@qq.com\"},\"sameAs\":[\"http:\\\/\\\/ncglobalhealth.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lung Cancer Targeted Therapy Resistance & Immunotherapy","description":"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ncglobalhealth.com\/ru\/lung-cancer-targeted-therapy-resistance-immunotherapy\/","og_locale":"ru_RU","og_type":"article","og_title":"Lung Cancer Targeted Therapy Resistance & Immunotherapy","og_description":"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.","og_url":"https:\/\/ncglobalhealth.com\/ru\/lung-cancer-targeted-therapy-resistance-immunotherapy\/","og_site_name":"ncglobalhealth.com","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61591372681524","article_published_time":"2026-10-13T02:21:00+00:00","article_modified_time":"2026-10-13T02:21:01+00:00","og_image":[{"width":1254,"height":1254,"url":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp","type":"image\/webp"}],"author":"admin@qq.com","twitter_card":"summary_large_image","twitter_misc":{"\u041d\u0430\u043f\u0438\u0441\u0430\u043d\u043e \u0430\u0432\u0442\u043e\u0440\u043e\u043c":"admin@qq.com","\u041f\u0440\u0438\u043c\u0435\u0440\u043d\u043e\u0435 \u0432\u0440\u0435\u043c\u044f \u0434\u043b\u044f \u0447\u0442\u0435\u043d\u0438\u044f":"6 \u043c\u0438\u043d\u0443\u0442"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#article","isPartOf":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/"},"author":{"name":"admin@qq.com","@id":"https:\/\/ncglobalhealth.com\/#\/schema\/person\/1340f27ee6eb785edcfbca839ac6f110"},"headline":"Lung Cancer Targeted Therapy Resistance: Reawakening the Immune System","datePublished":"2026-10-13T02:21:00+00:00","dateModified":"2026-10-13T02:21:01+00:00","mainEntityOfPage":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/"},"wordCount":924,"commentCount":0,"publisher":{"@id":"https:\/\/ncglobalhealth.com\/#organization"},"image":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp","keywords":["Biological Immunotherapy","Lung Cancer","NSCLC","Oncology Referral","Precision Oncology","Targeted Therapy Resistance"],"articleSection":["Precision Oncology"],"inLanguage":"ru-RU","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/","url":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/","name":"Lung Cancer Targeted Therapy Resistance & Immunotherapy","isPartOf":{"@id":"https:\/\/ncglobalhealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#primaryimage"},"image":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp","datePublished":"2026-10-13T02:21:00+00:00","dateModified":"2026-10-13T02:21:01+00:00","description":"Facing lung cancer targeted therapy resistance? Discover how advanced biological immunotherapy and combination strategies offer new clinical hope.","breadcrumb":{"@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#breadcrumb"},"inLanguage":"ru-RU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/"]}]},{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#primaryimage","url":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp","contentUrl":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/10\/lung-cancer-targeted-therapy-resistance-immunotherapy.webp","width":1254,"height":1254,"caption":"Microscopic visualization of biological immunotherapy targeting lung cancer cells after resistance"},{"@type":"BreadcrumbList","@id":"https:\/\/ncglobalhealth.com\/lung-cancer-targeted-therapy-resistance-immunotherapy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/ncglobalhealth.com\/"},{"@type":"ListItem","position":2,"name":"Lung Cancer Targeted Therapy Resistance: Reawakening the Immune System"}]},{"@type":"WebSite","@id":"https:\/\/ncglobalhealth.com\/#website","url":"https:\/\/ncglobalhealth.com\/","name":"ncglobalhealth.com","description":"","publisher":{"@id":"https:\/\/ncglobalhealth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ncglobalhealth.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ru-RU"},{"@type":"Organization","@id":"https:\/\/ncglobalhealth.com\/#organization","name":"ncglobalhealth.com","url":"https:\/\/ncglobalhealth.com\/","logo":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/ncglobalhealth.com\/#\/schema\/logo\/image\/","url":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/08\/logo-nuojian.webp","contentUrl":"https:\/\/ncglobalhealth.com\/wp-content\/uploads\/2026\/08\/logo-nuojian.webp","width":1600,"height":1213,"caption":"ncglobalhealth.com"},"image":{"@id":"https:\/\/ncglobalhealth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61591372681524","https:\/\/www.instagram.com\/novacareintl\/"]},{"@type":"Person","@id":"https:\/\/ncglobalhealth.com\/#\/schema\/person\/1340f27ee6eb785edcfbca839ac6f110","name":"admin@qq.com","image":{"@type":"ImageObject","inLanguage":"ru-RU","@id":"https:\/\/secure.gravatar.com\/avatar\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c614e05aa99e567f640b959f95fac2ca9ff998cf1c46a8778a09cea453ba2fea?s=96&d=mm&r=g","caption":"admin@qq.com"},"sameAs":["http:\/\/ncglobalhealth.com"]}]}},"_links":{"self":[{"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/posts\/287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/comments?post=287"}],"version-history":[{"count":1,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/posts\/287\/revisions"}],"predecessor-version":[{"id":289,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/posts\/287\/revisions\/289"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/media\/288"}],"wp:attachment":[{"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/media?parent=287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/categories?post=287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ncglobalhealth.com\/ru\/wp-json\/wp\/v2\/tags?post=287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}